Warning: Constant WP_DEBUG already defined in /www/wwwroot/ovaryresearch.com/wp-config.php on line 103

Warning: Constant WP_DEBUG_LOG already defined in /www/wwwroot/ovaryresearch.com/wp-config.php on line 104

Warning: Constant WP_DEBUG_DISPLAY already defined in /www/wwwroot/ovaryresearch.com/wp-config.php on line 105
Genome-edited Cells | Product categories | ovaryresearch.com
Home / Products / Genome-edited Cells

Genome-edited Cells

Genome-edited Cells are engineered using technologies like CRISPR/Cas9, TALENs, or ZFNs to introduce genetic modifications. Our portfolio includes genome-edited cells for knockout, overexpression, and reporter cell lines. Gene-edited cells are available in multiple backgrounds. CRISPR edited cells are generated using CRISPR-Cas9 ribonucleoproteins (RNPs) or lentiviral vectors, with high efficiency and specificity. CRISPR Cas9 edited cells have specific insertions or deletions (indels) or precise edits via homology-directed repair (HDR). Genome engineering services and products include custom cell line generation, validation, and quality control. Gene knockout cell lines have targeted disruption of a specific gene, resulting in loss of protein expression; they are used for functional genomics, drug target validation, and pathway mapping. CRISPR knockout cell lines are validated for loss of protein expression by sequencing. CRISPR KO cell line is available for thousands of human and mouse genes. Crispr modified cells may have multiplex edits (two or more genes disrupted simultaneously) using multiple guide RNAs.

In loss-of-function studies, knockout cell lines and ko cell lines are widely used to disrupt gene function. For gain-of-function analysis, overexpression cell lines are routinely generated. The demand for ready-made knockout tools is reflected in the frequent use of ko cell lines. When targeted validation of a single gene is required, a gene knockout cell line is the preferred model. Whether a single knockout cell line or a KO cell line for high‑throughput screening is needed, these standard formats are well established in functional genomics research.

Researchers use CRISPR knockout cell lines to study gene function in cancer, development, and metabolism. Knockout cell line pairs with rescue experiments using cDNA expression to confirm specificity. Gene edited cell lines are used for disease modeling, including introducing patient-specific mutations into isogenic backgrounds. Our genome-edited cells are sequence-validated (Sanger sequencing). Whether you need CRISPR KO cell line for drug target validation, or conditional knockout cells for developmental studies, our Genome-edited Cells category supports your functional genomics research with high-quality, validated products.

Showing 12 of 41986 results

EIF4B Knockout Marc-145 Cell Line

The EIF4B Knockout Marc-145 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from Marc-145 kidney epithelial cells, engineered to disrupt the EIF4B gene. EIF4B…
Cat. No. ARG43832

Eif2a Knockout Vero Cell Line

The Eif2a Knockout Vero Cell Line is a CRISPR/Cas9-edited knockout cell model from Vero kidney epithelial cells (Chlorocebus aethiops). Disrupting EIF2A, which recruits initiator Met-tRNA…
Cat. No. ARG43831

EGFR Knockout HK-2 Cell Line

The EGFR Knockout HK-2 Cell Line is a CRISPR/Cas9-edited human cell line with targeted disruption of the epidermal growth factor receptor (EGFR) gene. Utilizing the…
Cat. No. ARG43830

Egfr Knockout B16 Cell Line

The Egfr Knockout B16 Cell Line is a CRISPR/Cas9-edited knockout cell line featuring targeted disruption of the Egfr gene in the B16 murine melanoma background.…
Cat. No. ARG43829

EEF1AKMT3 Knockout THP-1 Cell Line

The EEF1AKMT3 Knockout THP-1 Cell Line is a CRISPR/Cas9-edited human monocytic leukemia cell line with targeted disruption of the EEF1AKMT3 methyltransferase gene. This model enables…
Cat. No. ARG43828

DTX3L Knockout THP-1 Cell Line

The DTX3L Knockout THP-1 Cell Line is a CRISPR/Cas9-edited human monocytic leukemia cell line with targeted disruption of DTX3L, an E3 ubiquitin ligase that partners…
Cat. No. ARG43827

DPP4 Knockout IPEC-J2 Cell Line

The DPP4 Knockout IPEC-J2 Cell Line is a CRISPR/Cas9-edited porcine jejunal epithelial knockout model with targeted disruption of the DPP4 gene. DPP4 is a serine…
Cat. No. ARG43826

DPH1 Knockout Vero Cell Line

The DPH1 Knockout Vero Cell Line is a CRISPR/Cas9-edited knockout cell line in the Vero kidney epithelial background, designed to disrupt the DPH1 gene. DPH1…
Cat. No. ARG43825

DOP1A Knockout AGS Cell Line

The DOP1A Knockout AGS Cell Line is a CRISPR/Cas9-edited human knockout cell line that abolishes DOP1A expression in AGS gastric adenocarcinoma cells. DOP1A is a…
Cat. No. ARG43824

DNMT3B Knockout HaCaT Cell Line

The DNMT3B Knockout HaCaT Cell Line provides a CRISPR/Cas9-mediated loss-of-function model of the de novo DNA methyltransferase DNMT3B in human HaCaT keratinocytes. Disruption of DNMT3B…
Cat. No. ARG43823

CASP3 Knockout AGS Polyclonal Cells

CASP3 Knockout AGS Polyclonal Cells is a knockout polyclonal cell population. The CASP3 was knocked out in the AGS cells using the CRISPR RNP technique.
Cat. No. ARG42437

CASP2 Knockout huh-7 Polyclonal Cells

CASP2 Knockout huh-7 Polyclonal Cells is a knockout polyclonal cell population. The CASP2 was knocked out in the huh-7 cells using the CRISPR RNP technique.
Cat. No. ARG42432

Loading products...